COMMUNIQUÉS West-GlobeNewswire

Thought Leadership & Innovation Foundation Announces Partnership with Paradigm to Support Limb Loss and Preservation Registry

19/09/2024 - 16:20

MCLEAN, Va., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Thought Leadership & Innovation Foundation (TLI) , a not-for-profit organization that works at the nexus of science, technology and public health, today announces a [...]

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 août 2024

19/09/2024 - 16:04

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 août 2024 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, les [...]

Rejuveron Life Sciences AG Rebrands as Centenara Labs AG and Provides Latest Clinical Updates

19/09/2024 - 16:00

Shareholders approve name change and rebranding to Centenara Labs AG (“Centenara”) Rebrand positions business for strategic initiatives designed to support development of therapies for regenerative medicine and age- [...]

Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th

19/09/2024 - 16:00

Bright Minds Biosciences announced the initiation of Phase 2 clinical trial of BMB-101 in a group of drug-resistant epilepsies and will discuss the details of the BREAKTHROUGH clinical trial on September 25th. The event [...]

IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology

19/09/2024 - 16:00

Nashville, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”), a leader in innovative healthcare solutions, proudly announces the launch of an entirely new [...]

Leap Distributors Acquires Leap Surgical and DUB Enterprises: Partnership Positions Company for Continued Growth

19/09/2024 - 15:47

DALLAS, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Leap Distributors has acquired Leap Surgical and DUB Enterprises, two privately owned and nationally recognized medical device firms. Effective immediately, the three companies [...]

Bavarian Nordic Receives EMA Approval of Mpox Vaccine for Adolescents

19/09/2024 - 15:45

MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA Represents the second EMA approval of an MVA-BN-based vaccine for a younger population COPENHAGEN, [...]

Immix Biopharma Announces Dr. Raymond Comenzo, Internationally Recognized AL Amyloidosis Expert, Director of the Myeloma and Amyloid Program at Tufts Medical Center, Joins Scientific Advisory Board

19/09/2024 - 15:31

Dr. Comenzo was the senior author of the landmark Andromeda trial results published in the New England Journal of Medicine in 2021, resulting in the first FDA-approved therapy for AL amyloidosis Dr. Comenzo was the lead [...]

FibroBiologics Engages Southern Star Research as CRO in Australia

19/09/2024 - 15:31

Southern Star Research will provide CRO services for FibroBiologics in Australia HOUSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company [...]

Labviva Introduces Real Time Inventory Management System for Life Sciences Purchasing

19/09/2024 - 15:00

Enterprise procure-to-payment provider advances AI automation for inventory and purchase intelligence BOSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Labviva , the leading AI procurement platform for life sciences, today [...]

NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024

19/09/2024 - 15:00

CARMEL, Ind., Sept. 19, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and [...]

Floré Unveils World’s First Line of Probiotics for Neurodiversity

19/09/2024 - 15:00

New Science-Driven Products Result from Joint Autism Spectrum Disorder Research with Arizona State University SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Floré , a leader in gut health testing and customized [...]

PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics

19/09/2024 - 15:00

Strategic partnership aims to further develop Cube’s award-winning AI guided platform for Software as a Service (SaaS) for the private sector and large healthcare systems and diagnostic to support clinicians and [...]

International Myeloma Foundation Launches Myelo: The First AI-Powered Responsive Chatbot to Provide Compassionate Myeloma Support for Patients, Care Partners, and Healthcare Professionals

19/09/2024 - 14:45

Partners with ZS Associates and AWS to Develop Groundbreaking First-of-its-kind Gen AI Companion STUDIO CITY, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is proud to announce [...]

Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults

19/09/2024 - 14:31

BlueCross BlueShield of North Carolina and Louisiana Medicaid Increase Coverage for Patients with Depression MALVERN, Pa., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology [...]

Safety Shot Partners with Launchpad to Tap into the Large and Influential College Student Market

19/09/2024 - 14:30

Launchpad’s Network All Roads Travel (ART) Will Help Raise Brand Awareness for Safety Shot Among Millions of U.S. College Students JUPITER, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Safety Shot , Inc. (Nasdaq: SHOT) (“ [...]

RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer

19/09/2024 - 14:30

Published data shows that chemotherapy delivered via TAMP with prior chemoradiation in Locally Advanced Pancreatic Cancer observed an Overall Survival of 27-months LOS ALTOS, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- [...]

Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

19/09/2024 - 14:30

Topline results expected in fourth quarter of 2024 GLEN ALLEN, Va., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company [...]

Intelligent Bio Solutions Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Operational Highlights

19/09/2024 - 14:30

- Fourth-quarter revenue of $0.73 million, up 64% year-over-year – - Full-year revenue of $3.11 million, up 148% year-over-year – - As of June 30, 2024, the Company had $6.30 million in cash - NEW YORK, Sept. 19, 2024 ( [...]